Factor Xa Inhibitors: S1 Binding Interactions of a Series of N-{(3S)-1-[(1S)-1-Methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfonamides
Citations Over TimeTop 10% of 2007 papers
Abstract
Factor Xa inhibitory activities for a series of N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}sulfonamides with different P1 groups are described. These data provide insight into binding interactions within the S1 primary specificity pocket; rationales are presented for the derived SAR on the basis of electronic interactions through crystal structures of fXa-ligand complexes and molecular modeling studies. A good correlation between in vitro anticoagulant activities with lipophilicity and the extent of human serum albumin binding is observed within this series of potent fXa inhibitors. Pharmacokinetic profiles in rat and dog, together with selectivity over other trypsin-like serine proteases, identified 1f as a candidate for further evaluation.
Related Papers
- → Ligand binding to I2 imidazoline receptor: The role of lipophilicity in quantitative structure—activity relationship models(1998)32 cited
- → Molecular modeling studies and in vitro bioactivity evaluation of a set of novel 5-nitro-heterocyclic derivatives as anti-T. cruzi agents(2009)23 cited
- → 3D molecular lipophilicity potential profiles: a new tool in molecular modeling(1988)123 cited
- → Structure-activity relationships of rationally designed AMACR 1A inhibitors(2018)12 cited
- → Lipophilicity and Related Molecular Properties as Determinants of Pharmacokinetic Behaviour(2000)17 cited